Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
LG Chem officially develops new anti-cancer therapeutic drugs
On April 1st, LG Chem announced that it has signed a strategic cooperation agreement with Frontier Medicines of the United States regarding the upcoming Phase I clinical trial of a new anti-cancer drug candidate “FMC-220.” LG Chem will obtain exclusive global research and commercialization licensing rights. Through this cooperation, LG Chem will be responsible for global market development and commercialization outside of China, and will pay an upfront payment to Frontier Medicines, followed by phased payments for research and development, commercialization costs, and sales licensing fees.